ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2023

Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial.

Theodoros Karampitsakos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.